Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Well Known Equity Indices are widely watched benchmarks that reflect overall market performance. This intro explains what they measure and why investors track them.
20,004 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Banks and financial-services shares are under pressure as rising yields meet renewed fears about private-credit lende...
US-based crypto funds lead weekly inflows, pushing total crypto fund flows above $1 billion for a third straight week...
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
Markets rally as rate expectations shift, lifting banks and fintechs. This week’s financial stocks week highlights th...
Bitcoin is acting as a fast-price detector for geopolitical risk, with intraday moves tied to crisis headlines rather...
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
Morgan Stanley trims its U.S. growth outlook after energy costs erode the uplift from tax refunds. The revision highl...
April brought a notable rally for Plug Power. This piece breaks down the forces behind the surge, what it signals for...
A rising retirement-income approach aims to reduce lifetime federal taxes by sequencing withdrawals. With RMDs and sh...
Applied Materials is set to report Q2 results after the close, as investors weigh demand signals for AI chips and adv...
A U.S.-listed ETF now prioritizes balance-sheet quality in developed markets, offering overseas exposure without weak...